Contact Us
Drug Search Results
More Filters [+]

Oxaprozin

Alternative Names: oxaprozin, daypro
Latest Update: 2023-09-14
Latest Update Note: News Article

Product Description

Oxaprozin, a nonsteroidal anti-inflammatory drug (NSAID) under consideration for approval by the Food and Drug Administration, is characterized as a propionic acid. By inhibiting cyclo-oxygenase, oxaprozin decreases the formation of prostaglandin (PG) precursors from arachidonic acid, resulting in decreased PG biosynthesis and reduced pain and inflammatory responses.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/1617910/)

Mechanisms of Action: COX1 Inhibitor,COX2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Belgium | Bulgaria | Canada | Chile | China | Egypt | Germany | Greece | India | Ireland | Italy | New Zealand | Pakistan | Peru | Portugal | Slovenia | South Africa | Taiwan | Turkey | United States

Approved Indications: Arthritis, Juvenile | Arthritis, Rheumatoid | Arthritis | Osteoarthritis

Known Adverse Events: Constipation | Diarrhea | Dyspepsia

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Oxaprozin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

09/14/2023

News Article

 Antipyretic Analgesics Market 2023 Industry Size, Shares, Segment and Forecast up to 2031

12/07/2022

News Article

 Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

01/28/2022

News Article

 Topical Analgesic Market New Innovations Trends, Research, Global Share and Growth Factor

12/10/2021

News Article

 2021 Research Report on the Oxaprozin (CAS 21256-18-8) Global Market - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions